Potentially Inappropriate Prescription Associated to Multimorbidity (PIMyC)

Corporacion Parc Tauli

Status: Completed

Conditions: Chronic Disease

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT02830425

PI15/00552

Details and patient eligibility

About

A prospective multicenter cohort study in 5 hospitals in Spain will be initiated in 2016.

Objectives:

1. To estimate and describe patterns of multimorbidity and polypharmacy in patients over 64 admitted for a chronic disease exacerbation.
2. To analyze the potentially inappropriate prescribing (PPI) drugs according to STOPP / START (SS) criteria.
3. To evaluate the relationship between multimorbidity and PPI and adverse medication (RAM) preventable reaction.

The cohort will include 800 patients >64 years admitted in internal medicine and / or geriatric department of 5 hospitals of the National Health Service. Application of the SS criteria (released in 2015) on admission and at discharge, and collection of demographic and clinical variables including comorbidities, baseline chronic medication, geriatric syndromes, functional capacity and RAM. Descriptive analysis and bivariate parametric or nonparametric tests will be applied to analyze relationship between morbidity, polypharmacy, SS criteria and RAM. Intraobserver agreement will be assessed for SS criteria. Multiple regression techniques will be applied, where the dependent variable will be the PPI or the RAM.

Enrollment: 740 patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient admitted to the Internal Medicine or Geriatrics department
• Admitted to hospital because of an exacerbation of any previous chronic condition

Exclusion criteria

• Terminal ill patients at admission
• Patients with lower forecast life than 1 year
• Patient admitted to the hospital only because an acute problem
• In patient home care